Comparison of ALK status between primary and corresponding lymph node metastatic tumors in lung cancer patients

BACKGROUND: The anaplastic lymphoma kinase (ALK) protein has recently become a promising target in the treatment of non-small cell lung carcinomas(NSCLC) patients with ALK translocation because of the high response rates obtained with an ALK inhibitor. ALK translocations are present in approximately...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Gao, Qiqi, Ma, Honghai, Wang, Bo, Yao, Yake, Zhou, Jianya, Zhou, Jianying
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2017
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5752485/
https://ncbi.nlm.nih.gov/pubmed/29312572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22294
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items